Fennec Historical Valuation

FENC Stock  USD 6.23  0.01  0.16%   
Some fundamental drivers such as market cap or Fennec Pharmaceuticals enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Fennec Pharmaceuticals valuation indicators such as Enterprise Value of 92.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Fennec Pharmaceuticals's future value.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.

About Fennec Valuation Data Analysis

Valuation is the financial process of determining what Fennec Pharmaceuticals is worth. Fennec Pharmaceuticals valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Fennec Pharmaceuticals valuation ratios help investors to determine whether Fennec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fennec with respect to the benefits of owning Fennec Pharmaceuticals security.

Fennec Pharmaceuticals Valuation Data Chart

The current year's Market Cap is expected to grow to about 108.1 M. The current year's Enterprise Value is expected to grow to about 92.9 M

Enterprise Value

Enterprise Value (or EV) is usually referred to as Fennec Pharmaceuticals theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Fennec Pharmaceuticals debt, but would also pocket its cash. Enterprise Value is more accurate representation of Fennec Pharmaceuticals value than its market capitalization because it takes into account all of Fennec Pharmaceuticals existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.04)
Revenue Per Share
1.814
Quarterly Revenue Growth
0.07
Return On Assets
0.027
Return On Equity
(10.06)
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.